Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis Pharmaceuticals
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participated or completed a GSK sponsored pazopanib study and remains eligible for continued treatment with pazopanib and lapatinib (if on combination therapy).
Able to understand and provide written informed consent
Women and men agree to use protocol specific birth control measures
You may not be if
The subject has a treatment related serious adverse event that remains unresolved or unstable or had pazopanib permanently stopped in a previous study because of intolerate or because it was unsuccessful in treating your cancer
If you are pregnant or breast feeding
Your doctor does not think you would be a good candidate for the study
Poorly controlled high blood pressure
Subject is unwilling or unable to follow the procedures outlined in the protocol.
